CLASS II Drug recall · Reported 12 Jun 2013 · FDA Enforcement Report

Dallergy Chewable Tablets, Antihistamine, Nasal Decongestant recalled

TG United is recalling Dallergy Chewable Tablets, Antihistamine, Nasal Decongestant, distributed in Florida, Louisiana, Mississippi, South Carolina, Texas. The recall was initiated on 30 Jan 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot# 12B001 Exp. 01/14; Lot# 12B001 Exp. 01/14; Lot# 12B002 Exp 01/14; Lot# 12F013 Exp. 05/2014; Lot# 12F013 Exp. 05/2014.
Quantity recalled8296 bottles - 100-count and 153,028 Bulk tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-518-2013
FDA event ID
64188
Recalling firm
TG United, Brooksville, FL
Classification
Class II
Status
Terminated
Recall initiated
30 Jan 2013
FDA classified
4 Jun 2013
Reported
12 Jun 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Drug class
Nasal Sprays

Timeline

30 Jan 2013Recall initiated by company
4 Jun 2013Classified by FDA+125 days
12 Jun 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Product as listed by the FDA

Dallergy CHEWABLE TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Laser Pharmaceuticals, LLC, Greenville, SC 29615, NDC 16477-152-01

Where it was distributed

FL, MS, SC, LA and TX

FloridaLouisianaMississippiSouth CarolinaTexas

Questions about this recall

Is Dallergy Chewable Tablets, Antihistamine, Nasal Decongestant recalled?

Yes. TG United recalled Dallergy Chewable Tablets, Antihistamine, Nasal Decongestant on 30 Jan 2013. The recall is Class II and its status is Terminated. Recall number D-518-2013.

Why was it recalled?

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Which lots are affected?

Lot# 12B001 Exp. 01/14; Lot# 12B001 Exp. 01/14; Lot# 12B002 Exp 01/14; Lot# 12F013 Exp. 05/2014; Lot# 12F013 Exp. 05/2014.

Where was it sold?

FL, MS, SC, LA and TX

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from TG United

All 44